Japanese Study Evaluating the Effects of Telithromycin in Children With Acute Otitis Media
Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
The primary objective is to assess the safety of telithromycin (HMR3647) 20 mg/kg qd for 5
days in children with acute otitis media (AOM).
Secondary objectives are to assess Efficacy, Pharmacokinetics and Acceptability of
telithromycin 20 mg/kg qd for 5 days in children with AOM.